Literature DB >> 2795586

Malignant mesothelioma.

E Heyderman, P D Ridley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2795586      PMCID： PMC1292317          DOI： 10.1177/014107688908200933

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  18 in total

1.  Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach.

Authors:  H Battifora; M I Kopinski
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

2.  Cytokeratin-specific monoclonal antibodies are reactive with tumours of smooth muscle derivation. An immunocytochemical and biochemical study using antibodies to intermediate filament cytoskeletal proteins.

Authors:  A J Norton; J A Thomas; P G Isaacson
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

3.  Monoclonal antibody to cytokeratin for use in routine histopathology.

Authors:  C A Makin; L G Bobrow; W F Bodmer
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

4.  Human lung tumours may coexpress different classes of intermediate filaments.

Authors:  K C Gatter; M S Dunnill; G N Van Muijen; D Y Mason
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

5.  The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.

Authors:  G A Blobel; R Moll; W W Franke; K W Kayser; V E Gould
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

6.  Immunohistochemical staining for vimentin and keratin in malignant mesothelioma.

Authors:  A Churg
Journal:  Am J Surg Pathol       Date:  1985-05       Impact factor: 6.394

7.  Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.

Authors:  A Dewar; M Valente; N P Ring; B Corrin
Journal:  J Pathol       Date:  1987-08       Impact factor: 7.996

8.  Distribution of lysozyme, alpha 1-Antichymotrypsin and alpha 1-Antitrypsin in adenocarcinomas of the stomach and large intestine. An immunohistochemical study.

Authors:  C Kittas; K Aroni; L Kotsis; C S Papadimitriou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1982

9.  Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.

Authors:  I Lee; J A Radosevich; G Chejfec; Y X Ma; W H Warren; S T Rosen; V E Gould
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

10.  A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2.

Authors:  E Heyderman; I Strudley; G Powell; T C Richardson; J L Cordell; D Y Mason
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640
View more
  1 in total

1.  Pneumothorax and malignant mesothelioma in patients over the age of 40.

Authors:  J D Sheard; W Taylor; A Soorae; M G Pearson
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.